Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
ZBHZimmer Biomet
FinDog View：Neutral
| Metric | TMO | ZBH |
|---|
| Close | 648.43 | 96.78 |
| Market Cap | $240B | $18.4B |
| 1M | +10.75% | −1.45% |
| P/E (TTM) | 34.4 | 22.1 |
| Forward P/E | 21.8 | 10.8 |
| P/E 5-Yr Percentile | 65 | 25 |
| P/S | 5.2 | 2.1 |
| P/B | 4.6 | 1.4 |
| Dividend Yield | 0.29% | 1.04% |
| Latest Quarter Revenue | $12.0B | $2.2B |
| Revenue YoY | +10.5% | +4.8% |
| Gross Margin | — | 70.8% |
| Latest Quarter EPS | 4.68 | 1.03 |
| Avg Post-Earnings Move | ±1.2% | ±2.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.36% | 5.11% |
| 90-Day Net Insider Buying | −$38.9M | −$0.82M |
TMO · Revenue, Last 8 Quarters ($B)
ZBH · Revenue, Last 8 Quarters ($B)
